Improving the use and safety of medications in women through sex/gender and race/ethnicity analysis: Introduction

Journal of Women's Health

Volumn 14, Issue 1, 2005, Pages 12-15

  Correa de Araujo, Rosaly ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CONTRACEPTIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BIRTH DEFECT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG USE; ETHNOLOGY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE QUALITY; HEALTH EDUCATION; HEART ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MEDICATION ERROR; OUTCOMES RESEARCH; PHARMACEUTICAL CARE; PHARMACODYNAMICS; PHARMACOGENETICS; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; TORSADE DES POINTES;

EID: 14644440806     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2005.14.12     Document Type: Article

References (25)

1. Clancy CM. AHRQ's FY2005 budget request: New mission, new vision. Health Serv Res 2004;39:xi.
2. Meyer GS, Battles J, Hart JC, Tang N. The U.S. Agency for Healthcare Research and Quality's activities in patient safety. Int J Qual Health Care 2003;15:i25.
3. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18820 patients. Br Med J 2004; 329:15-19.
4. Grissinger MC, Kelly K. Reducing the risk of medication errors in women. J Wom Health 2005;14:61.
5. Kaltenbach ML, Dukic S. Sex-related differences in human pharmacokinetics and pharmacodynamics. XX vs XY 2003;1:59.
6. Berg MJ. Gender analysis of medications: Challenges to the sciences and profession of pharmacy. Introduction. XX vs XY 2003;1:49.
7. Anderson GD. Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Wom Health 2005;14:19.
8. Donovan MD. Sex and racial differences in pharmacological response: Effect of route of administration and drug delivery system on pharmacokinetics. J Wom Health 2005;14:30.
9. Smolensky MH, Hermida RC, Haus E, Portaluppi F, Reinberg A. Biological rhythms, medication safety, and women's health. J Wom Health 2005;14:38.
10. Anthony M. Male/female differences in pharmacology: Safety issues with QT prolonging drugs. J Wom Health 2005;14:47.
11. Uhl K, Kennedy DL, Kweder SL. Risk management strategies in the physicians' Desk Reference product labels for pregnancy category X drugs. Drug Safety 2002;25:885.
12. Gardner J, Miller L. Promoting the safety and use of hormonal contraceptives. J Wom Health 2005;14:53.
13. Gurwitz JH. The age-gender interface in geriatric pharmacotherapy. J Wom Health 2005;14:68.
14. Perry BA, Turner LW. A prediction model for polypharmacy: Are older, educated women more susceptible to an adverse drug event? J Women Aging 2001;13:39.
15. Correa-de-Araujo R, Miller GE, Banthin JS, Trinh Y. Gender differences in drug use and expenditure in a privately insured population of older adults. J Wom Health 2005;14:73.
16. Baghdadi G. Gender and medicines: An international public health perspective. J Wom Health 2005;14:82.
17. Col NF. Challenges in translating research into practice. J Wom Health 2005;14:87.
18. Department of Health and Human Services National Institutes of Health. Monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research. Bethesda, MD: NIH, 2003.
19. Society for Women's Health Research. Senate appropriations committee instructs the national institutes of health to make "sex-based biology an integral part" of research. Available at www.womenshealthresearch. org/press/releases/092004.htm
20. Institute of Medicine. To err is human: Building a safer health system. Washington, DC: National Academy Press, 1999.
21. Wood SF. The regulatory perspective of gender analysis. XX vs XY. 2003;1:64.
22. Medicines in development for women. Washington, DC: Pharmaceutical Research and Manufacturers of America, 2004.
23. Pharmaceutical Research and Manufacturers Association. ClinicalStudyResults.org Available at www.clinicalstudyresults.org /
24. Centers for Education and Research on Therapeutics: Overview. AHRQ Publication No. 02-P025. Rockville, MD: Agency for Healthcare Research and Quality, 2004. www.ahrq.gov/clinic/certsovr.htm
25. Correa-de-Araujo R. It's your health: Use your medications safely. J Wom Health 2005;14:16.